Derma Sciences, Inc. (DSCI) Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion And Progress In Launching New Placental-Derived Tissue Products
3/14/2014 7:11:47 AM
Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013. Highlights of the fourth quarter of 2013 and recent weeks include:
•Expanded the Advanced Wound Care (AWC) product line and entered the $500 million skin substitute market by licensing the AMNIO family of placental-derived tissue products
Help employers find you! Check out all the jobs and post your resume.
comments powered by